ZVSA

ZyVersa Therapeutics
ZVSA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

2 hedge funds and large institutions have $124K invested in ZyVersa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$101K
2
+$23K

Top Sellers

1
-$7M
2
-$6.99M
3
-$6.94M
4
SCM
Saba Capital Management
New York
-$5.97M
5
YCM
Yakira Capital Management
Connecticut
-$5.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$101K
2
$23K
3
–
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2